REBECCA NEWBY: Open Payments
NPI 1457685265 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,212 in 126 payments from 26 companies in 2025. Trend: 2023 $1,684 · 2024 $1,917 · 2025 $2,212
Food & beverage: $2,212
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $443 |
| Amgen Inc. | 14 | $156 |
| Otsuka America Pharmaceutical, Inc. | 11 | $153 |
| Vanda Pharmaceuticals Inc. | 9 | $152 |
| Grifols USA, LLC | 6 | $140 |
| Aimmune Therapeutics, Inc. | 5 | $119 |
| Lundbeck LLC | 5 | $110 |
| Axsome Therapeutics, Inc. | 6 | $105 |
| GENZYME CORPORATION | 5 | $96 |
| Novo Nordisk Inc | 5 | $91 |
Products named: REXULTI, QULIPTA, VRAYLAR, FANAPT, Prolastin-C Liquid, DUPIXENT, MOUNJARO, EVENITY.
Industry payments across ID — which companies pay providers there.
